ストックスクリーナーアプリを入手
171.16
2.56%
-4.50
Danaher Corp (DHR) 最新ニュース
Danaher Corp. stock (US2358511028): Shares near 52-week low after mixed Q1 2026 results and analyst - AD HOC NEWS
Danaher Corp. stock underperforms Friday when compared to competitors - MarketWatch
Danaher Corp. may be the smartest bet in biotech right now - MSN
IDBS brings BioPharma leaders together at flagship i3 2026 forum in Boston - PR Newswire
Danaher Corp. Stock (US2358511028): Analyst Downgrades and 52-Week Low Test - AD HOC NEWS
Pregnancy Detection Kits Market Analysis Report 2026 - GlobeNewswire Inc.
Danaher shareholders approve incentive plan and elect directors at annual meeting - Investing.com
Danaher (NYSE: DHR) investors approve incentive plan, pay and auditor - Stock Titan
Here’s What Morgan Stanley Thinks About Danaher Corporation (DHR) - Insider Monkey
DAP.DE Stock Price, Quote & Chart | DANAHER CORP (FRA:DAP) - ChartMill
Danaher to webcast CEO remarks from May 13 Las Vegas conference - Stock Titan
Danaher to Present at Bank of America Securities Healthcare Conference - marketscreener.com
Agilent Taps Danaher Deal Lawyer As Chief Legal Officer - Law360
Danaher Corpdeclares quarterly cash dividend of $0.40 per share payable July 31, 2026 - marketscreener.com
Masimo Corp. stockholders adopted Danaher merger agreement May 1 - MLex
Danaher to acquire Masimo (NASDAQ: MASI) in $180 per share cash deal - Stock Titan
Danaher declares $0.40 quarterly dividend payable July 31 - Investing.com
Danaher declares $0.40 quarterly dividend payable July 31 By Investing.com - Investing.com Canada
Danaher shareholders get $0.40 a share dividend on July 31 - Stock Titan
Danaher Corporation announces Quarterly dividend, payable on July 31, 2026 - marketscreener.com
Danaher (NYSE: DHR) director exercises options and sells 1,358 shares - Stock Titan
We Think You Can Look Beyond Danaher's (NYSE:DHR) Lackluster Earnings - Moomoo
Masimo Shareholders Approve $180 Per Share Acquisition by Danaher, Merger Expected to Close in 2026 - Minichart
Masimo shareholders give green light to $10B acquisition by Danaher - MassDevice
Global Plasmid DNA Manufacturing Market Anticipates Impressive Growth Trajectory at a CAGR of ~18% by 2034 | DelveInsight - GlobeNewswire Inc.
Masimo Shareholders Approve $9.9B Sale to Danaher - Orange County Business Journal
Masimo shareholders approve its $9.9B acquisition by Danaher - Modern Healthcare News
Masimo Shareholders OK $9.9B Merger Deal with Danaher - Medical Product Outsourcing
Masimo shareholders approve $180 per share Danaher acquisition - Investing.com
Masimo Shareholders Approve Acquisition by Danaher - marketscreener.com
Masimo (NASDAQ: MASI) shareholders back $180 cash acquisition by Danaher - Stock Titan
Masimo nears Danaher sale after shareholder vote backs cash merger - Stock Titan
Investors Can Find Comfort In Danaher's (NYSE:DHR) Earnings Quality - Yahoo Finance
Masimo (MASI) 10-K/A adds governance, CEO pay terms and Danaher merger plans - Stock Titan
[144] DANAHER CORP /DE/ SEC Filing - Stock Titan
Danaher Corporation stock hits 52-week low at $174.97 By Investing.com - Investing.com UK
Danaher Corporation stock hits 52-week low at $174.97 - Investing.com
DHR SEC FilingsDanaher Corporation 10-K, 10-Q, 8-K Forms - Stock Titan
Single-use Bioprocessing Market Size Advancing at 11.0% CAGR | - openPR.com
FRANKLIN RISING DIVIDENDS VIP FUND's Danaher Corp(DHR) Holding History - GuruFocus
[CERT] DANAHER CORP /DE/ Certification Filing | DHR SEC FilingForm CERT - Stock Titan
Danaher Corporation: China Headwinds Persist—But Is the Core Business Strong Enough to Offset? - Smartkarma
Danaher Corp. Stock (US2358511028): Q1 2026 Earnings Set for Release Today - AD HOC NEWS
Danaher Corporation (DHR) Announces Issuance of €3 Billion in Se - GuruFocus
Danaher Corp (DHR) Stock Price, Trades & News - GuruFocus
Vanguard reports 47.4M-share stake in Danaher (NYSE: DHR) via 13G - Stock Titan
€2.98B Danaher (NYSE: DHR) euro notes to support Masimo acquisition - Stock Titan
Danaher posts $6B quarter and raises 2026 profit outlook - Stock Titan
Is It Time To Reassess Danaher (DHR) After Recent Share Price Weakness - simplywall.st
Danaher Q1 earnings beat estimates, life sciences sales up Y/Y - MSN
Danaher to buy medical tech firm Masimo for $9.9 billion - MSN
Danaher (NYSE: DHR) director granted 231.809 phantom shares - Stock Titan
Danaher (NYSE: DHR) director defers fees into 17.248 phantom share units - Stock Titan
Danaher (NYSE: DHR) director awarded new phantom share units - Stock Titan
Danaher (DHR) director Linda Filler adds 20.121 phantom shares in deferred award - Stock Titan
Danaher (NYSE: DHR) director adds 252 phantom shares via deferred fees - Stock Titan
Danaher (NYSE: DHR) director receives 187.894 phantom share award - Stock Titan
Bulk Filtration Market Report 2026, Competitive Analysis of 3M, Eaton, Parker-Hannifin, Pentair, Merck, Danaher, Mann+Hummel - GlobeNewswire Inc.
Former Fortive CEO who led $16B-to-$25B rise joins CD&R - Stock Titan
Point of Care Diagnostics Market | Abbott Laboratories, BD, Danaher Corp, Nova Biomedical Corporation etc. - openPR.com
Danaher Corp. stock outperforms competitors on strong trading day - MarketWatch
1.99%
1.32%
大文字化:
|
ボリューム (24 時間):